Imaging Technology

MARCH 18, 2024

This collaboration also addresses the ongoing clinical need in breast cancer therapy for the development of an inexpensive, robust, and accurate technique to identify the response, within weeks, of breast cancer to neoadjuvant chemotherapy. milla1cf Mon, 03/18/2024 - 07:00 March 18, 2024 — QT Imaging Holdings, Inc. ,

Radiation Oncology 105

Radiation Oncology Health Science Radiation Ultrasound 105

Imaging Technology

OCTOBER 2, 2024

1, 2024 — At ASTRO 2024, Jay Detsky, MD, PhD, radiation oncologist at Sunnybrook Health Sciences Centre (Toronto, Ontario, Canada), presented initial cancer control outcomes from the UNITED trial (Unity-Based MR-Linac Guided Adaptive Radiotherapy for High Grade Glioma). tim.hodson Wed, 10/02/2024 - 13:28 Oct.

Radiation 52

Radiation Radiation Oncology Health Science Clinic 52

AuntMinnie

MARCH 14, 2024

The company is collaborating with the Department of Radiation Oncology and Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, and the University of Illinois, Urbana-Champaign. and Canada.

Radiation Oncology 52

Radiation Oncology Health Science Imaging Radiation 52

Imaging Technology

OCTOBER 3, 2023

Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting. On a five-point scale of acceptability, 90% of clinical stakeholders rated the new workflow as four or higher.

Diagnostic 105

Diagnostic Radiation Oncology Radiation Computed Tomography 105

AuntMinnie

APRIL 4, 2024

Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. When, in 2022, the U.S.

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since the U.S. please insert video here.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since the U.S.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52